LifeSci Advisors, LLC (LSA) Initiates Coverage on Rockwell Medical Technologies

NEW YORK--(BUSINESS WIRE)--LifeSci Advisors, LLC., a leading provider of investment research and investor relations services in the life sciences sector, today announced that it has initiated coverage on Rockwell Medical (NASDAQ: RMTI), a fully-integrated biopharmaceutical company offering innovative products and services targeting end-stage renal disease (ESRD), chronic kidney disease, and iron deficiency anemia.

MORE ON THIS TOPIC